Cisplatin + docetaxel improves survival over cisplatin + mitomycin C in hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei: a retrospective study based on propensity score matching
Objective Pseudomyxoma peritoneum (PMP) of appendiceal origin poses significant treatment challenges with hyperthermic intraperitoneal chemotherapy (HIPEC) regimens offering viable outcomes. This study aimed to compare the efficacy and safety profiles of two HIPEC regimens: cisplatin + docetaxel (CD...
Saved in:
| Main Authors: | Yu-Bin Fu, Rui Yang, Yan-Dong Su, Ru Ma, Tian Wei, Yang Yu, Bing Li, Yan Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | International Journal of Hyperthermia |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/02656736.2025.2467296 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cytoreductive interventions in combination with hyperthermic intraperitoneal chemoperfusion in pseudomyxoma
by: A. G. Abdullayev, et al.
Published: (2014-08-01) -
Analysis of risk factors for major post-operative complications following intraperitoneal hyperthermic perfusion for pseudomyxoma peritonei: A retrospective cohort study
by: Xiang Zhang, et al.
Published: (2025-04-01) -
Challenges in choice of the treatment strategy for patients with recurrent pseudomyxoma peritonei
by: A. G. Abdullaev, et al.
Published: (2019-04-01) -
Prophylactic oophorectomy is recommended in female patients with pseudomyxoma peritonei of an appendiceal origin
by: Fengxian Fu, et al.
Published: (2025-07-01) -
CHALLENGES IN CHOICE OF THE TREATMENT STRATEGY FOR PATIENTS WITH RECURRENT PSEUDOMYXOMA PERITONEI
by: A. G. Abdullaev, et al.
Published: (2019-06-01)